No Data
No Data
Landfar Bio-medicine Co., Ltd's (SZSE:000504) 30% Share Price Surge Not Quite Adding Up
Landfar Bio-medicine Co., Ltd (SZSE:000504) shares have continued their recent momentum with a 30% gain in the last month alone. But the gains over the last month weren't enough to make shareholder
Nanhua Biology (000504.SZ): The company does not yet have synthetic biotechnology
Gelonghui, May 8, 丨 Nanhua Biology (000504.SZ) said on the investor interactive platform that the company does not yet have synthetic biotechnology-related technology. The company's biomedical business is mainly cell storage, and also studies applications and services related to stem cells and immune cells. Among them, cell storage includes stem cell storage and immune cell storage. Applied research mainly includes stem cells to treat lung damage, mesenchymal stem cells treat gestational diabetes, basic and clinical research on stem cells to treat kidney disease, research on the molecular mechanisms of umbilical cord mesenchymal stem cell exosomes in skin damage repair, and umbilical cord mesenchymal stem cells
Landfar Bio-medicine Co., Ltd's (SZSE:000504) Biggest Owners Are Private Equity Firms Who Got Richer After Stock Soared 17% Last Week
Key Insights Significant control over Landfar Bio-medicine by private equity firms implies that the general public has more power to influence management and governance-related decisions 51% of the
Nanhua Biotech (000504.SZ): Net loss of 2.777 million yuan in the first quarter
Gelonghui, April 29丨Nanhua Biotech (000504.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 25.973,900 yuan, down 25.23% from the previous year; net profit attributable to shareholders of listed companies was 2.777 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 3.834 million yuan; basic earnings per share.
There's Reason For Concern Over Landfar Bio-medicine Co., Ltd's (SZSE:000504) Massive 45% Price Jump
Those holding Landfar Bio-medicine Co., Ltd (SZSE:000504) shares would be relieved that the share price has rebounded 45% in the last thirty days, but it needs to keep going to repair the recent damag
Landfar Bio-medicine (SZSE:000504) Adds CN¥439m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 46%
Over the last month the Landfar Bio-medicine Co., Ltd (SZSE:000504) has been much stronger than before, rebounding by 45%. But if you look at the last five years the returns have not been good. Af
No Data